ABCC4 and breast carcinoma: We have now shown that breast cancer subtypes have different expression profiles of the PGE2 pathway members and that MRP4 expression was strongly elevated in aggressive (IDC, TNBC, basal type) breast cancer cell lines relative to less aggressive, luminal cell lines.